{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:11:12Z","timestamp":1791407472496,"version":"4.3.3"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inflammatory bowel disease (IBD) is a multisystem disease impacting various body systems including musculoskeletal, ocular, skin, hepatobiliary, pulmonary, cardiac, and haematological systems. The extraintestinal manifestations of IBD are frequent, common in both ulcerative colitis (UC) and Crohn\u2019s disease (CD), and impact the morbidity and mortality of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Embase, Embase classic, and PubMed databases were searched between January 1979 and December 2021. A random effects model was performed to find the pooled prevalence of joint, ocular, and skin extraintestinal manifestations of UC and CD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifty-two studies were included that reported on 352\u2009454 patients. The prevalence of at least 1 joint, ocular, or skin extraintestinal manifestation in all IBD, UC, and CD was 24%, 27%, and 35% respectively. The prevalence between UC and CD were similar for pyoderma gangrenosum and axial joint manifestations. Ocular manifestations were found to be more common in CD than in UC. Peripheral joint manifestations and erythema nodosum were found to be more common in CD than UC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>To our knowledge, this is the first meta-analysis that reports on the prevalence of at least 1 joint, ocular, or skin extraintestinal manifestation in IBD. Our results are largely consistent with figures and statements quoted in the literature. However, our findings are based on significantly larger cohort sizes. Thus, our results have the potential to better power studies and more accurately counsel patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izad061","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T11:02:51Z","timestamp":1681297371000},"page":"230-239","source":"Crossref","is-referenced-by-count":86,"title":["Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis"],"prefix":"10.1093","volume":"30","author":[{"given":"Yakup","family":"Kilic","sequence":"first","affiliation":[{"name":"Department of Radiology, University College London Hospitals NHS Foundation Trust , 235 Euston Road, London NW1 2BU , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahed","family":"Kamal","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Northern Hospital , Epping, Melbourne , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Jaffar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust , Uxbridge, UB9 6JH , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8326-0761","authenticated-orcid":false,"given":"Danujan","family":"Sriranganathan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Whipps Cross University Hospital, Barts Health NHS Trust , Whipps Cross Road, London E11 1NR , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Nabil","family":"Quraishi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust , Bordesley Green East, Birmingham, B9 5SS , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P","family":"Segal","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Northern Hospital , Epping, Melbourne , Australia"},{"name":"Department of Medicine, University of Melbourne , Parkville, Melbourne , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"2024020200272502400_CIT0001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5)","author":"Alatab","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2024020200272502400_CIT0002","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2165\/11638120-000000000-00000","article-title":"Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease","volume":"72)","author":"Trikudanathan","year":"2012","journal-title":"Drugs."},{"key":"2024020200272502400_CIT0003","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00054725-200111000-00005","article-title":"Clinical outcome of Crohn\u2019s disease: analysis according to the Vienna classification and clinical activity","volume":"7)","author":"Veloso","year":"2001","journal-title":"Inflamm Bowel Dis."},{"key":"2024020200272502400_CIT0004","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","article-title":"Frequency and risk factors for extraintestinal manifestations in the Swiss Inflammatory Bowel Disease Cohort","volume":"106)","author":"Vavricka","year":"2011","journal-title":"Am J Gastroenterol."},{"key":"2024020200272502400_CIT0005","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management","volume":"161)","author":"Rogler","year":"2021","journal-title":"Gastroenterology."},{"key":"2024020200272502400_CIT0006","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21)","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"2024020200272502400_CIT0007","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.3748\/wjg.v17.i22.2702","article-title":"Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome","volume":"17)","author":"Veloso","year":"2011","journal-title":"World J Gastroenterol."},{"key":"2024020200272502400_CIT0008","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ibd.20807","article-title":"Mucocutaneous manifestations in inflammatory bowel disease","volume":"15)","author":"Y\u00fcksel","year":"2009","journal-title":"Inflamm Bowel Dis."},{"key":"2024020200272502400_CIT0009","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1148\/rg.2017160121","article-title":"Beyond the bowel: extraintestinal manifestations of inflammatory bowel disease","volume":"37)","author":"Olpin","year":"2017","journal-title":"Radiographics."},{"key":"2024020200272502400_CIT0010","doi-asserted-by":"crossref","first-page":"175628481986514","DOI":"10.1177\/1756284819865142","article-title":"Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study","volume":"12)","author":"Biedermann","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"key":"2024020200272502400_CIT0011","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2024020200272502400_CIT0012","first-page":"e14010","article-title":"Cardiovascular manifestations in inflammatory bowel disease: a systematic review of the pathogenesis and management of pericarditis","volume":"13)","author":"Patel","year":"2021","journal-title":"Cureus"},{"key":"2024020200272502400_CIT0013","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00535-022-01903-6","article-title":"Renal manifestations in inflammatory bowel disease: a systematic review","volume":"57)","author":"van Hoeve","year":"2022","journal-title":"J Gastroenterol."},{"key":"2024020200272502400_CIT0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12794","article-title":"Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease","volume":"40)","author":"Gizard","year":"2014","journal-title":"Aliment Pharmacol Ther."},{"key":"2024020200272502400_CIT0015","article-title":"Chapter 5: Systematic reviews of prevalence and incidence","volume-title":"JBI Manual for Evidence Synthesis.","author":"Munn","year":"2020"},{"key":"2024020200272502400_CIT0016","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2991\/jegh.k.200330.001","article-title":"Extraintestinal manifestations of inflammatory bowel disease in Middle Eastern patients","volume":"10)","author":"Adam","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"2024020200272502400_CIT0017","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1007\/s10620-020-06424-x","article-title":"Extraintestinal manifestations in patients with inflammatory bowel disease: study based on the ENEIDA Registry","volume":"66)","author":"Algaba","year":"2021","journal-title":"Dig Dis Sci."},{"key":"2024020200272502400_CIT0018","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/jgh.12352","article-title":"Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease","volume":"29)","author":"Ampuero","year":"2014","journal-title":"J Gastroenterol Hepatol."},{"key":"2024020200272502400_CIT0019","doi-asserted-by":"crossref","first-page":"1143.3","DOI":"10.1136\/annrheumdis-2016-eular.2516","article-title":"AB0699 enthesitis and sacroiliitis prevalence determined by doppler ultrasonography and magnetic resonance imaging in patients with inflammatory bowel disease","volume":"75)","author":"Aparicio","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"2024020200272502400_CIT0020","doi-asserted-by":"crossref","first-page":"SS4","DOI":"10.1016\/S0016-5085(15)30009-3","article-title":"9 Extraintestinal manifestations of inflammatory bowel disease are significantly more frequent among African Americans compared to Caucasians","volume":"148)","author":"Badamas","year":"2015","journal-title":"Gastroenterology."},{"key":"2024020200272502400_CIT0021","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/14397595.2016.1211229","article-title":"Association of inflammatory bowel disease with ankylosing spondylitis and rheumatoid arthritis: a nationwide population-based study","volume":"27)","author":"Bae","year":"2017","journal-title":"Mod Rheumatol."},{"key":"2024020200272502400_CIT0022","doi-asserted-by":"crossref","first-page":"1255.2","DOI":"10.1136\/annrheumdis-2016-eular.5687","article-title":"AB1034 the epidemiology of the rheumatic manifestations associated with inflammatory bowel disease: the preliminary data from a hospital-based cohort study in Istanbul: Table 1","volume":"75)","author":"Cakir","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"2024020200272502400_CIT0023","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s10620-016-4195-1","article-title":"Extra-gastrointestinal manifestations of inflammatory bowel disease may be less common than previously reported","volume":"61)","author":"Card","year":"2016","journal-title":"Dig Dis Sci."},{"key":"2024020200272502400_CIT0024","first-page":"479","article-title":"Extraintestinal manifestations in inflammatory bowel disease-results from North-Eastern Romania","volume":"121)","author":"Cordoneanu","year":"2017","journal-title":"Med-Surg J."},{"key":"2024020200272502400_CIT0025","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/acr.23323","article-title":"Prevalence of sacroiliitis in inflammatory bowel disease using a standardized computed tomography scoring system","volume":"70)","author":"Chan","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2024020200272502400_CIT0026","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1053\/j.gastro.2019.01.127","article-title":"P068 extraintestinal manifestations and their impact on real-world treatment patterns and outcomes among patients with ulcerative colitis","volume":"156)","author":"Chapman","year":"2019","journal-title":"Gastroenterology."},{"key":"2024020200272502400_CIT0027","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2310\/7750.2014.13209","article-title":"Mucocutaneous manifestations of inflammatory bowel disease in Turkey","volume":"18)","author":"Demir","year":"2014","journal-title":"J Cutan Med Surg."},{"key":"2024020200272502400_CIT0028","first-page":"15","article-title":"Crohn\u2019s disease - regional differences and natural disease course: National and European trends","author":"Goldis","year":"2018"},{"key":"2024020200272502400_CIT0029","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1177\/0300060518781404","article-title":"Rheumatic manifestations of inflammatory bowel diseases: a study from the Middle East","volume":"46)","author":"Hammoudeh","year":"2018","journal-title":"J Int Med Res."},{"key":"2024020200272502400_CIT0030","doi-asserted-by":"crossref","first-page":"e0211554","DOI":"10.1371\/journal.pone.0211554","article-title":"The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort","volume":"14)","author":"Hiller","year":"2019","journal-title":"PLoS One."},{"key":"2024020200272502400_CIT0031","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.1016\/S1873-9946(14)60746-7","article-title":"P626 extraintestinal manifestations in Romanian IBD patients \u2013 evaluation of a cohort of over 1000 patients","volume":"8)","author":"Iacob","year":"2014","journal-title":"J Crohns Colitis"},{"key":"2024020200272502400_CIT0032","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/00365521.2014.991752","article-title":"Extraintestinal manifestations in Crohn\u2019s disease and ulcerative colitis: results from a prospective, population-based European inception cohort","volume":"50)","author":"Isene","year":"2015","journal-title":"Scand J Gastroenterol."},{"key":"2024020200272502400_CIT0033","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/1346-8138.15676","article-title":"Various skin manifestations related to inflammatory bowel disease: a nationwide cross-sectional study on the Korean population","volume":"48)","author":"Jo","year":"2021","journal-title":"J Dermatol."},{"key":"2024020200272502400_CIT0034","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/ecco-jcc\/jjv232","article-title":"Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease","volume":"10)","author":"Karmiris","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2024020200272502400_CIT0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12157-016-0698-9","article-title":"Les manifestations extradigestives au cours de la maladie de Crohn","volume":"11)","author":"Krati","year":"2017","journal-title":"J Afr Hepato Gastroenterol."},{"key":"2024020200272502400_CIT0036","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v9.i10.2300","article-title":"Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study","volume":"9)","author":"Lakatos","year":"2003","journal-title":"World J Gastroenterol."},{"key":"2024020200272502400_CIT0037","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5217\/ir.2017.15.3.380","article-title":"Ophthalmologic manifestations in patients with inflammatory bowel disease","volume":"15)","author":"Lee","year":"2017","journal-title":"Intest Res"},{"key":"2024020200272502400_CIT0038","first-page":"450","article-title":"Ulcerative colitis: epidemiology, clinical features and associated factors with surgical treatment in a tertiary hospital in Mexico","volume":"87)","author":"de Le\u00f3n-Rend\u00f3n","year":"2019","journal-title":"Cir Cir"},{"key":"2024020200272502400_CIT0039","doi-asserted-by":"crossref","first-page":"S464","DOI":"10.1093\/ecco-jcc\/jjx002.869","article-title":"P746 Clinical characteristic of Crohn\u2019s disease patients in Polish population","volume":"11)","author":"Lodyga","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2024020200272502400_CIT0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/BF02365438","article-title":"Intestinal and extraintestinal complications of Crohn\u2019s disease: predictors and cumulative probability of complications","volume":"29)","author":"Maeda","year":"1994","journal-title":"J Gastroenterol."},{"key":"2024020200272502400_CIT0041","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/CEG.S136383","article-title":"Characterization and prevalence of spondyloarthritis and peripheral arthritis among patients with inflammatory bowel disease","volume":"10)","author":"Malaty","year":"2017","journal-title":"Clin Exp Gastroenterol."},{"key":"2024020200272502400_CIT0042","doi-asserted-by":"crossref","first-page":"S268","DOI":"10.1016\/S1873-9946(13)60665-0","article-title":"P644 Factors associated to the presence of spondyloarthritis in patients with inflammatory bowel disease. AQUILES study","volume":"7)","author":"Mar\u00edn-Jim\u00e9nez","year":"2013","journal-title":"J Crohns Colitis"},{"key":"2024020200272502400_CIT0043","article-title":"Successful management of extra-intestinal manifestations of inflammatory bowel disease: 1963","volume":"110)","author":"Martinez","year":"2015","journal-title":"Am J Gastroenterol."},{"key":"2024020200272502400_CIT0044","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4103\/0378-6323.45102","article-title":"Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study","volume":"74)","author":"Moravvej","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"2024020200272502400_CIT0045","first-page":"16","article-title":"Extraintestinal manifestations in patients with inflammatory bowel disease (IBD)","volume-title":"The 10th National Symposium on Inflammatory Bowel Diseases","author":"Muzica","year":"2018"},{"key":"2024020200272502400_CIT0046","first-page":"582","article-title":"FRI0406 prevalence and significance of radiographic Sacroiliitis in a large inflammatory bowel disease population","volume-title":"Ann Rheum Dis.","author":"Nangit","year":"2016"},{"key":"2024020200272502400_CIT0047","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ecco-jcc\/jjx126","article-title":"Ankylosing spondylitis and axial spondyloarthritis in patients with long-term inflammatory bowel disease: results from 20 years of follow-up in the IBSEN study","volume":"12)","author":"Ossum","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2024020200272502400_CIT0048","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12009-000-0064-8","article-title":"Ocular complications in inflammatory bowel disease","volume":"32)","author":"Ozdemir","year":"2000","journal-title":"Ann Ophthalmol"},{"key":"2024020200272502400_CIT0049","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12664-021-01181-9","article-title":"Prevalence of extraintestinal manifestations in ulcerative colitis and associated risk factors","volume":"40)","author":"Rawal","year":"2021","journal-title":"Indian J Gastroenterol."},{"key":"2024020200272502400_CIT0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00054725-200405000-00005","article-title":"Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study","volume":"10)","author":"Ricart","year":"2004","journal-title":"Inflamm Bowel Dis."},{"issue":"1","key":"2024020200272502400_CIT0051","first-page":"1","article-title":"The prevalence and characterization of axial spondyloarthritis among veterans with inflammatory bowel disease","volume":"1","author":"Salem","year":"2019","journal-title":"Crohns Colitis 360"},{"key":"2024020200272502400_CIT0052","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.14309\/00000434-201802001-00044","article-title":"Clinical and sociodemographic characteristics of inflammatory bowel disease in Mexico: a Multi-center and Nationwide Study (EPIMEX-IBD): P-044","volume":"113)","author":"Andrea","year":"2018","journal-title":"Am J Gastroenterol."},{"key":"2024020200272502400_CIT0053","first-page":"340","article-title":"THU0241 Musculoskeletal involvement in inflammatory bowel disease\u2019s patients: a mono centric experience","volume-title":"Ann Rheum Dis.","author":"Sedie","year":"2018"},{"key":"2024020200272502400_CIT0054","doi-asserted-by":"crossref","first-page":"346","DOI":"10.15403\/jgld-3818","article-title":"Risk factors for extraintestinal manifestations in inflammatory bowel diseases - data from the Romanian National Registry","volume":"30)","author":"Singeap","year":"2021","journal-title":"J Gastrointestin Liver Dis."},{"key":"2024020200272502400_CIT0055","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2298\/VSP1310947S","article-title":"Correlation between extraintestinal manifestations and clinical parameters with the histologic activity index in patients with inflammatory bowel diseases","volume":"70)","author":"Stuli\u0107","year":"2013","journal-title":"Vojnosanit Pregl."},{"key":"2024020200272502400_CIT0056","first-page":"S408","article-title":"P652. Treatment, evolution and associated risk factors of extraintestinal manifestations in patients with inflammatory bowel disease","volume":"9)","author":"Syed","year":"2015","journal-title":"J Crohns Colitis"},{"key":"2024020200272502400_CIT0057","first-page":"A33","article-title":"Study of extraintestinal manifestations of inflammatory bowel disease","volume":"29)","author":"Thayumanavan","year":"2010","journal-title":"Indian J Gastroenterol."},{"key":"2024020200272502400_CIT0058","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00296-005-0044-9","article-title":"The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease","volume":"26)","author":"Turkcapar","year":"2006","journal-title":"Rheumatol Int."},{"key":"2024020200272502400_CIT0059","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/ecco-jcc\/jjaa096","article-title":"The IBIS-Q [IBD identification of Spondyloarthritis Questionnaire]: a novel tool to detect both axial and peripheral arthritis in inflammatory bowel disease patients","volume":"14)","author":"Variola","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2024020200272502400_CIT0060","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/MIB.0000000000000429","article-title":"Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss Inflammatory Bowel Disease Cohort","volume":"21)","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"2024020200272502400_CIT0061","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ecco-jcc\/jjx178","article-title":"Cutaneous morbidity among inflammatory bowel disease patients: a cohort study","volume":"12)","author":"Vide","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2024020200272502400_CIT0062","first-page":"1739","article-title":"1293 Incidence of sacroiliitis in inflammatory bowel disease: a signle-centre study from tianjin, china","volume-title":"Ann Rheum Dis.","author":"Xiaoyan","year":"2018"},{"key":"2024020200272502400_CIT0063","doi-asserted-by":"crossref","first-page":"e0200363","DOI":"10.1371\/journal.pone.0200363","article-title":"Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients","volume":"13)","author":"Yang","year":"2018","journal-title":"PLoS One."},{"key":"2024020200272502400_CIT0064","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2133.1982.tb01731.x","article-title":"Further evidence for an association between psoriasis, Crohn\u2019s disease and ulcerative colitis","volume":"106)","author":"Yates","year":"1982","journal-title":"Br J Dermatol."},{"key":"2024020200272502400_CIT0065","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1097\/MEG.0b013e3283583e5c","article-title":"The trend in newly diagnosed Crohn\u2019s disease and extraintestinal manifestations of Crohn\u2019s disease in central China: a retrospective study of a single center","volume":"24)","author":"Yi","year":"2012","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"2024020200272502400_CIT0066","doi-asserted-by":"crossref","first-page":"17463","DOI":"10.3748\/wjg.v20.i46.17463","article-title":"Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients","volume":"20)","author":"Zippi","year":"2014","journal-title":"World J Gastroenterol."},{"key":"2024020200272502400_CIT0067","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","article-title":"The First European Evidence-based Consensus on extra-intestinal manifestations in inflammatory bowel disease","volume":"10)","author":"Harbord","year":"2016","journal-title":"J Crohns Colitis"},{"issue":"Suppl_3","key":"2024020200272502400_CIT0068","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68)","author":"Lamb","year":"2019","journal-title":"Gut."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izad061\/49865492\/izad061.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/2\/230\/56542226\/izad061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/2\/230\/56542226\/izad061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T19:28:32Z","timestamp":1706815712000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/30\/2\/230\/7115910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":68,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,4,12]]},"published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izad061","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2,1]]},"published":{"date-parts":[[2023,4,12]]}}}